- Home
- CERS vs MUE Comparison
CERS vs MUE Comparison
Compare CERS & MUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- MUE
- Stock Information
- Founded
- CERS 1991
- MUE 1999
- Country
- CERS United States
- MUE United States
- Employees
- CERS N/A
- MUE N/A
- Industry
- CERS EDP Services
- MUE Investment Bankers/Brokers/Service
- Sector
- CERS Technology
- MUE Finance
- Exchange
- CERS Nasdaq
- MUE Nasdaq
- Market Cap
- CERS 255.0M
- MUE 206.2M
- IPO Year
- CERS 1997
- MUE N/A
- Fundamental
- Price
- CERS $1.30
- MUE $9.81
- Analyst Decision
- CERS Strong Buy
- MUE
- Analyst Count
- CERS 2
- MUE 0
- Target Price
- CERS $3.50
- MUE N/A
- AVG Volume (30 Days)
- CERS 1.2M
- MUE 62.6K
- Earning Date
- CERS 10-29-2025
- MUE 01-01-0001
- Dividend Yield
- CERS N/A
- MUE 4.09%
- EPS Growth
- CERS N/A
- MUE N/A
- EPS
- CERS N/A
- MUE N/A
- Revenue
- CERS $192,510,000.00
- MUE N/A
- Revenue This Year
- CERS $30.03
- MUE N/A
- Revenue Next Year
- CERS $9.37
- MUE N/A
- P/E Ratio
- CERS N/A
- MUE N/A
- Revenue Growth
- CERS 13.25
- MUE N/A
- 52 Week Low
- CERS $1.12
- MUE $8.53
- 52 Week High
- CERS $2.24
- MUE $10.17
- Technical
- Relative Strength Index (RSI)
- CERS 50.21
- MUE 70.26
- Support Level
- CERS $1.26
- MUE $9.37
- Resistance Level
- CERS $1.35
- MUE $9.55
- Average True Range (ATR)
- CERS 0.07
- MUE 0.08
- MACD
- CERS 0.01
- MUE 0.03
- Stochastic Oscillator
- CERS 51.72
- MUE 90.87
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About MUE Blackrock MuniHoldings Quality Fund II Inc.
BlackRock MuniHoldings Quality Fund II Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. The fund seeks to achieve its investment objective by investing in long-term, investment-grade municipal obligations exempt from U.S. federal income taxes.